GIandHepatology.com

How Should Gastrointestinal Bleeding of Obscure Origin Be Investigated?

Answer in brief: After adequate upper endoscopy and colonoscopy fail to identify a bleeding source, the small bowel becomes the major focus. Video capsule endoscopy is usually the first-line small-bowel test in a stable patient, while CT enterography, angiographic techniques, tagged red-cell imaging or urgent endoscopic/angiographic intervention are selected according to bleeding rate, hemodynamic stability and concern for obstruction or tumor.[1]

Use the modern term: suspected small-bowel bleeding

The older label “obscure GI bleeding” is increasingly reserved for bleeding that remains unexplained even after small-bowel evaluation. The first question is whether the original EGD and colonoscopy were adequate; missed upper- and lower-GI lesions remain common enough to matter.

Overt versus occult bleeding changes urgency

Overt bleeding includes melena or hematochezia; occult bleeding presents as iron-deficiency anemia or positive testing without visible blood. Hemodynamic instability takes priority over elegant localization: stabilize, reverse relevant coagulopathy when appropriate, and use urgent endoscopic or angiographic pathways.

Capsule endoscopy is central

ACG guidance supports video capsule endoscopy as a first-line small-bowel investigation after upper and lower sources have been excluded.[1] Yield is generally highest when performed close to an overt bleeding episode. Capsule retention risk should be considered in suspected obstruction, Crohn’s strictures or prior small-bowel surgery.

When enterography or deep enteroscopy is preferable

CT enterography is particularly useful when a mass, mural disease or obstruction is suspected or when capsule findings are negative but suspicion remains. Device-assisted enteroscopy is most valuable when a lesion requires biopsy, hemostasis or tattooing. Capsule often finds the target; enteroscopy treats it.

Common lesions

  • Small-bowel angioectasia, especially in older adults or those with chronic kidney disease/aortic stenosis.
  • NSAID-related ulceration and diaphragm disease.
  • Crohn’s disease.
  • Small-bowel tumors.
  • Meckel diverticulum in younger patients.
  • Dieulafoy lesions and less common vascular abnormalities.

A practical sequence

  1. Confirm that EGD and colonoscopy were adequate; repeat selectively if not.
  2. If stable, choose capsule endoscopy as the usual first small-bowel test.
  3. Use CT enterography when tumor, mural disease or obstruction is a concern.
  4. Use deep enteroscopy to biopsy or treat a known/suspected lesion.
  5. For brisk ongoing bleeding, consider CT angiography and interventional radiology pathways.
  6. If no source is found, manage iron deficiency and reassess if bleeding recurs.

Questions trainees should be able to answer

  • When is capsule endoscopy preferred to CT enterography?
  • Which patients need patency assessment before capsule?
  • What is the role of device-assisted enteroscopy?

Frequently asked questions

Should EGD and colonoscopy ever be repeated? Yes, selectively—particularly when quality was poor or the presentation strongly suggests a missed lesion.

What if capsule endoscopy is negative? Reassess the bleeding phenotype and consider enterography, repeat capsule during active bleeding, or deep enteroscopy depending on ongoing risk.

What is the most common small-bowel source in older adults? Angioectasia is among the most common findings.

Free further reading from Dr. Thomson

  • GI Practice Review — free book library
  • Endoscopy and Diagnostic Imaging — free book library

References

1. Gerson LB, Fidler JL, Cave DR, Leighton JA. ACG Clinical Guideline: Diagnosis and Management of Small Bowel Bleeding. Am J Gastroenterol. 2015;110:1265-1287. doi:10.1038/ajg.2015.246.

2. Thomson ABR. Endoscopy and Diagnostic Imaging. Parts I-II. CAPstone Academic Publishers; 2012.

3. Thomson ABR. Practice Review in Gastroenterology. CAPstone Academic Publishers; 2014.

Educational use only. This article is intended for clinicians and trainees and does not replace patient-specific medical judgment or local guidance.